ATEBRIOZ
Live / Applied — Statement of use — processing complete, to examiner (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 10 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97672294
- Mark type
- Stylized text
- Filed
- 10 Nov 2022
- Published for opposition
- 04 Jul 2023
- Attorney of record
- Karl M. Zielaznicki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of fibrotic disorders.
Owner
- Incyte Holdings Corporation, Wilmington, DE, US
- Incyte Holdings Corporation, Wilmington, DE, US
Prosecution history
- 09 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Aug 2026 — USE AMENDMENT FILED
- 28 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 23 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2026 — SOU EXTENSION 5 GRANTED
- 23 Feb 2026 — SOU EXTENSION 5 FILED
- 09 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED